What is the minimum Widal (Widal test) titer considered positive for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Widal Test Interpretation for Typhoid Fever Diagnosis

The serological Widal test lacks sensitivity and specificity and is not recommended for the diagnosis of typhoid fever. 1 Instead, blood cultures remain the gold standard diagnostic method, with the highest yield within the first week of symptom onset.

Diagnostic Value of Widal Test

Despite its limitations, in settings where blood culture facilities are unavailable, the following interpretations of Widal titers can be considered:

  • In endemic areas, a single Widal test with O or H agglutinin titers ≥1:80 may be considered positive with appropriate clinical context 2
  • Some studies suggest a cutoff titer of ≥1:160 for O antigen as having high specificity and positive predictive value 3
  • At a cut-off titer of O agglutinin ≥1:80, diagnostic sensitivity is 90% and specificity 87.3% 2
  • For H agglutinin ≥1:80, sensitivity is 90% and specificity 88.5% 2

Limitations of Widal Test

The Widal test has several significant limitations:

  • Poor sensitivity and specificity in endemic areas 1
  • High background titers in endemic populations (13.8% for O antigen and 8.0% for H antigen at titers ≥1:80) 4
  • False positives in patients with immunological disturbances (11.5%) 5
  • Variable results based on age, sex, and geographic region 6
  • Decreasing positivity rates over time (from 46.4% in 1991 to 25% in 1995) 4

Preferred Diagnostic Methods

Blood cultures should be prioritized over Widal testing:

  • Blood cultures have the highest yield within the first week of symptom onset 1
  • Sensitivity for blood cultures is reported as 40-80% 1
  • Bone marrow cultures have higher sensitivity than blood cultures 1
  • Stool and urine cultures become positive after the first week (sensitivity 35-65% and 0-58% respectively) 1

Newer Diagnostic Alternatives

Newer rapid serological tests detecting IgM against specific antigens (e.g., Typhidot, Typhidot-M, Tubex) have been developed but show mixed results 1. PCR techniques may be more reliable but are not widely available in endemic settings.

Clinical Implications

When blood culture facilities are unavailable:

  • A single Widal test with O or H agglutinin titers ≥1:80 may be considered presumptive evidence of typhoid fever when combined with appropriate clinical presentation 2
  • Higher titers (≥1:160 or ≥1:200) provide stronger evidence 3, 6
  • The concept of a single "diagnostic titer" is unreliable; clinical correlation is essential 6
  • False negatives are common in early disease (first week), and false positives occur in endemic areas and in patients with immunological disorders 4, 5

In conclusion, while the Widal test has significant limitations, in resource-limited settings where blood cultures are unavailable, titers of ≥1:80 for both O and H antigens may provide presumptive evidence of typhoid fever when interpreted alongside clinical findings.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Widal agglutination titres in the diagnosis of typhoid fever.

West African journal of medicine, 2007

Research

Value of a single Widal test in the diagnosis of typhoid fever.

The Indian journal of medical research, 1993

Research

100 years of Widal test & its reappraisal in an endemic area.

The Indian journal of medical research, 1997

Research

The Widal test in the diagnosis of typhoid fever in the transvaal.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.